Coxsackieviruses are non-enveloped viruses belonging to the picornaviridae family and enterovirus genus that possess linear single-stranded RNA as their genetic material. Based on their pathogenecity tested on mice, they are further categorized into group A and group B viruses. Group A viruses are known to cause skin and mucous membrane infections leading to disorders such as herpangina, hand-foot-and-mouth (HFM) disease and acute hemorrhagic conjunctivitis (AHC), whereas, group B viruses infect the pancreas, liver and heart leading to various conditions such as pericarditis, hepatitis, myocarditis and pleurodynia.
According to the estimations of Centers for Disease Control and Prevention (CDC), out of all the neonatal enterovirus infections from the year 1983 – 2003, coxsackievirus infections accounted for around 25% share. People from all age groups get infected by coxsackievirus but children are more susceptible to infection. Fetuses or newborns are at a high risk of infection if their mother gets infected during pregnancy. These viruses are found in the feces, fluid in blisters, nasal secretions and saliva of infected patients.
Patients infected with coxsackievirus are diagnosed by the appearance of blisters on the hands, mouth and feet. In rare instances, viral identification tests can be performed that involves the use of real time-PCR for amplification of the DNA sample. This type of test distinguishes the virus at the genus, species and subtype level of nomenclature. Tylenol (acetaminophen) is usually administered for symptomatic treatment to reduce fever; other treatment options include Benadryl (diphenhydramine). The coxsackievirus diagnostics market can be segmented on the basis of the type of diagnostic tests performed in various hospitals, private laboratories, etc., instrumentation and geography.
The major factors driving the growth of this market are increasing incidence of coxsackievirus infections, increased awareness among the public and rigorous government initiatives to reduce the incidences of these infections. Lack of resources and accessibility in remote areas is one of the key factors that may mask the growth of this market. Some of the leading players in this market include Abbott Laboratories, Danaher Corporation, Affymetrix, Inc., Bio-Rad Laboratories, Inc. and Hologic Corporation.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY – 12207